Clinical trial
Efficacy of Naltrexone in Women's Smoking Cessation
NCT00271024 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Naltrexone in Women's Smoking Cessation
- Lead sponsor
- University of Chicago
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2005
- Completion date
- March 31, 2010
- Enrollment
- 333 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
smoking, smoking cessation